Correction: Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity.

[This corrects the article DOI: 10.1136/rmdopen-2016-000412.][This corrects the article DOI: 10.1136/rmdopen-2016-000412.].

Calabrese C, Kirchner E, Kontzias K, et al. Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity. RMD Open 2017;3:e000412.

This article has been corrected since it first published. The third author of this paper should be cited as ‘Kontzias A’.